Company Filing History:
Years Active: 1985-1987
Title: Michael Toepert: Innovator in Corticoid Research
Introduction
Michael Toepert is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel corticoids. With a total of two patents to his name, Toepert's work has implications for medical treatments and drug formulations.
Latest Patents
Toepert's latest patents include "Novel 6,16-dimethylcorticoids their preparation and use" and "Novel 6, 16-dimethylcorticoids, their preparation and use." Both patents focus on compounds of Formula I, wherein the bond can be a single bond or a double bond. These innovations represent advancements in the preparation and application of corticoids, which are vital in various therapeutic areas.
Career Highlights
Michael Toepert is associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at Schering has allowed him to explore and develop new compounds that can enhance treatment options for patients. His expertise in the field has positioned him as a valuable asset to the company.
Collaborations
Toepert has collaborated with notable colleagues, including Klaus Annen and Henry Laurent. These partnerships have fostered an environment of innovation and have contributed to the successful development of his patented compounds.
Conclusion
Michael Toepert's contributions to corticoid research and his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to influence medical advancements and improve treatment options for various conditions.